ArticlePDF Available

ETAS, an Enzyme-treated Asparagus Extract, Attenuates Amyloid β-Induced Cellular Disorder in PC 12 Cells

SAGE Publications Inc
Natural Product Communications
Authors:

Abstract

One of the pathological characterizations of Alzheimer's disease (AD) is the deposition of amyloid beta peptide (Abeta) in cerebral cortical cells. The deposition of Abeta in neuronal cells leads to an increase in the production of free radicals that are typified by reactive oxygen species (ROS), thereby inducing cell death. A growing body of evidence now suggests that several plant-derived food ingredients are capable of scavenging ROS in mammalian cells. The purpose of the present study was to investigate whether enzyme-treated asparagus extract (ETAS), which is rich in antioxidants, is one of these ingredients. The pre-incubation of differentiated PC 12 cells with ETAS significantly recovered Abeta-induced reduction of cell viability, which was accompanied by reduced levels of ROS. These results suggest that ETAS may be one of the functional food ingredients with anti-oxidative capacity to help prevent AD.
ETAS, an Enzyme-treated Asparagus Extract, Attenuates Amyloid
-Induced Cellular Disorder in PC12 Cells
Junetsu Ogasawaraa,*, Tomohiro Itob, Koji Wakameb, Kentaro Kitadateb, Takuya Sakuraia, Shogo Satoa,
Yoshinaga Ishibashia, Tetsuya Izawac, Kazuto Takahashid, Hitoshi Ishidad, Ichiro Takabatakea,e,
Takako Kizakia and Hideki Ohnoa
aDepartment of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine,
Tokyo 181-8611, Japan
bAmino Up Chemical Co., Ltd., Hokkaido 004-0839, Japan
cGraduate School of Health and Sports Sciences, Doshisha University, Kyoto 610-0394, Japan
dThird Department of Internal Medicine, Kyorin University, School of Medicine, Tokyo 181-8611, Japan
eCelelign Orthodontic Clinic, Tokyo 102-0083, Japan
junetsu@ks.kyorin-u.ac.jp.
Received: October 31st, 2013; Accepted: January 8th, 2014
One of the pathological characterizations of Alzheimer’s disease (AD) is the deposition of amyloid beta peptide (A) in cerebral cortical cells. The deposition
of Ain neuronal cells leads to an increase in the production of free radicals that are typified by reactive oxygen species (ROS), thereby inducing cell death.
A growing body of evidence now suggests that several plant-derived food ingredients are capable of scavenging ROS in mammalian cells. The purpose
of the present study was to investigate whether enzyme-treated asparagus extract (ETAS), which is rich in antioxidants, is one of these ingredients. The
pre-incubation of differentiated PC 12 cells with ETAS significantly recovered A-induced reduction of cell viability, which was accompanied by reduced
levels of ROS. These results suggest that ETAS may be one of the functional food ingredients with anti-oxidative capacity to help prevent AD.
Keywords: Alzheimer’s disease, Amyloid beta, ETAS, ROS, PC 12 cell.
Alzheimer’s disease (AD) is a chronic neurodegenerative disease,
which gives rise to dementia through impairments in learning,
memory, and thought in the elderly. The number of people who
suffer from AD worldwide is predicted to reach 100 million by the
year 2050 [1]. The establishment of new medical treatments for AD
will undoubtedly have a critical role in the improvement of quality
of life (QOL) for human beings. It is widely accepted that the
pathological characteristics of AD feature two states: abnormal
accumulation of amyloid beta (A) peptide and intracellular
phosphorylated tau-protein. In particular, A-induced neuronal cell
toxicity is known to be accompanied by an accumulation of
intracellular reactive oxygen species (ROS) [2-5], which leads to
apoptotic cell death [6,7]. Thus, finding materials that will
contribute to a reduction in A-mediated ROS accumulation in
neuronal cells would be beneficial in the prevention of AD-induced
cellular disorder. It is assumed that diet therapy would have fewer
side effects than pharmaceutical therapy. Therefore, a survey of
food ingredients that could inhibit AD-induced cell toxicity could
be valuable in establishing a new treatment directed at the
prevention of AD.
Growing evidence now suggests that plant-derived polyphenols
have a direct effect on the suppression of ROS production in
neuronal cells [8-10]. Indeed, epigallocatechin gallate (EGCG), a
major compound of green tea polyphenol, has demonstrated a
protective effect against nitric oxide-induced apoptosis in neuronal
PC12 cells [11]. Also, 5-hydroxymethyl-2-furfural, which is widely
available in plant foods, is now known as a natural antioxidant in
mammalian cells [12, 13]. These results suggest that plant-derived
food ingredients might be natural neuroprotective substances via
activation of the ROS scavenging system. Enzyme-treated asparagus
Figure 1: Effect of ETAS on A-induced cell death in differentiated PC 12 cells. Cell
viability was assayed by MTT assay, as described in the Experimental section. Each
value represents the mean ± SD (n = 8).* P < 0.05.
extract (ETAS), which can be isolated from the stem segment of
green asparagus, comprises 5-hydroxymethyl-2-furfural and/or its
derivative [14]. ETAS is thus expected to be an agent that has an
inhibitory effect on A-induced neurotoxicity through its anti-
oxidant capacity.
In previous studies, PC12 pheochromocytoma cells have been
widely used as in vitro research models on AD because of a
differential ability to act as neurocytes. Indeed, several
phytochemical constituents and food ingredients now are known to
attenuate cell cytotoxicity with or without Ain PC12 cells [15-20].
Thus, an investigation using PC12 cells as a neurocyte model would
be useful for the functional evaluation of ETAS on A-mediated
neuronal cell cytotoxicity. In addition, AD has been tightly linked to
the cortical deposition of fibrillar A plaques, which are mainly
composed of A1-42 peptide [21,22], which suggests that the
NPC Natural Product Communications 2014
Vol. 9
No. 4
561 - 564
562 Natural Product Communications Vol. 9 (4) 2014 Ogasawara et al.
Figure 2: Effect of ETAS on A-induced cellular disorder in differentiated PC 12 cells.
Cellular disorder was assayed according to the LDH released from cells to the
incubation medium, as described in the Experimental section. Each value represents the
mean ± SD (n = 8).* P < 0.05.
Figure 3: Effect of ETAS on the A-induced production of ROS in differentiated PC
12 cells. Levels of ROS were assayed by DCFH-DA assay, as described in the
Experimental section. Each value represents the mean ± SD (n = 8).* P < 0.05.
addition of A1-42 peptide would be a suitable AD model for
cultured cells. The present study was focused on evaluating the
preventive effect of ETAS on A1-42-induced cellular disorder in
differentiated PC12 cells.
As shown in Figure 1, the addition of A1-42 to differentiated
PC12 cells revealed a significant decrease in cell viability compared
with non-treated control cells. In contrast, no significant change in
cell viability was observed by the addition of ETAS alone to
differentiated PC12 cells, suggesting that ETAS is safe as a food
ingredient-derived pharmaceutical additive [14]. It is worth noting
that Apeptide-induced cell death in these cells was significantly
inhibited by pre-treatment with ETAS (Figure 1). On the basis of
these results, the rate of lactate dehydrogenase (LDH) release in the
cell culture medium, another cell viability marker, was also
measured to confirm the current observations. As expected, the
A1-42-induced increase in LDH release was significantly
attenuated by the pre-addition of ETAS in differentiated neuronal
PC12 cells (Figure 2). These results indicate that ETAS has the
ability to protect against A-mediated cell death and/or membrane
damage in neuronal PC12 cells. Moreover, as a relevant
mechanism(s), A1-42 peptide-mediated cellular toxicity
reportedly activates the intracellular ROS production system [23].
Indeed, in Figure 3, the pre-treatment of ETAS significantly
inhibited the A-induced production of intracellular ROS levels,
although the addition of A1-42 alone to neuronal PC12 cells
provoked a significant increase in intracellular ROS levels
compared with non-treated control cells. These results suggest that a
reduction in intracellular ROS levels by ETAS also might be
associated with the ETAS-induced inhibition of cellular disorder in
neuronal PC12 cells.
It is noteworthy that A1-42-induced cellular toxicity in neuronal
PC12 cells was prevented by pre-treatment with ETAS. In recent
studies of A-mediated dysfunctional cells, plant foods such as
yuzu, i.e., Citrus junos Tanaka [24], Allium [25], and Panax
notoginseng [26] have inhibited hippocampal A accumulation,
DNA fragmentation, and caspase-3 activity, respectively. It is
noteworthy that the application of plant food-derived ingredients
such as limonene isolated from yuzu peel [24], aqueous extract of
Allium sativum [27], and water and ethanol extract of Panax
notoginseng [28] has been used to attenuate significantly
intracellular ROS levels, thereby improving the scavenging action
of oxidative stress in several cytotoxic cells. Moreover, 5-hydroxy-
methyl-2-furfural, which is a common Maillard reaction product
that is comprised of ETAS [14], has shown an anti-oxidant effect on
several types of cells [13, 29]. Consequently, in the present study,
plant food and its ingredient-mediated suppression of oxidative
stress would play a key role in the attenuation of cell viability by
the addition of A peptide, because cell death triggered by Ais
known to be accompanied by intracellular ROS production in PC12
cells [30, 31]. This concept has been supported by our results
whereby alterations in LDH releases are synchronized with the
generation of ROS in neuronal PC12 cells (Figures 2 and 3).
On the other hand, it is difficult to elucidate the mechanism
underlying the ETAS-induced suppression of ROS. However, it
may be logical to speculate that the attenuation of ROS by ETAS
occurred via the inhibitory action of a ROS production enzyme,
because 5-hydroxymethyl-2-furfural is known to act as an
inhibitor of xanthine oxidase, an oxidative enzyme [32]. Moreover,
5-hydroxymethyl-2-furfural is also known to increase the
expression of anti-oxidative enzymes glutathione peroxidase and
superoxide dismutase on the gene level [27]. Thus, the coordinated
effect of ETAS on a decrease in the excessive production of ROS,
and/or an increase in the removal of defective ROS, could be
associated with a reduction in ROS, which is upregulated by the
addition of A-peptide in neuronal PC12 cells.
In conclusion, ETAS has the capacity to prevent A-induced
cellular disorder via the suppression of intracellular ROS
production. Thus, ETAS is expected to prevent AD through its anti-
cytotoxic capacity.
Experimental
ETAS, an enzyme-treated asparagus extract: The safety of ETAS
as a pharmacological additive has been confirmed [14]. ETAS is
composed of a mixture of 5-hydroxymethyl-2-furfural and its
derivative, which is named asfural [14]. ETAS was dissolved in
DMSO, and freshly prepared solutions were used for each
experiment. ETAS is commercially available (Amino Up Chemical
Co., Ltd., Sapporo Japan).
Materials: PC12 cells were purchased from RIKEN BRC CELL
BANK (RIKEN, Tsukuba, Japan), A 1-42 from Anaspec
(Fremont, CA), DMEM medium and 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) from Sigma (St.Louis,
MO), dichlorofluorescin diacetate (DCFHDA) from Invitrogen
(Carlsbad, CA), horse serum from Gibco (BRL, Palo Alto, CA),
fetal bovine serum from MP Biomedicals, LLC (Solon, OH), and
the assay kit for LDH from Promega (Madison, WI). All other
chemicals and reagents were from Sigma.
Cell culture and assay procedures: PC12 cells were cultured with
growth medium that consisted of DMEM with 10% horse serum,
5% calf serum, 50 unit/mL penicillin and 100 mg/mL streptomycin.
Inhibitory effect of ETAS on amyloid beta-induced cellular disorder Natural Product Communications Vol. 9 (4) 2014 563
The cells (5×104 cells) were seeded in a 96-well plate and
incubated at 37°C for 24 h. Thereafter, the induction of
differentiation in the PC 12 cells was maintained at 37°C for 72 h
by adding 50 ng/mL of nerve growth factor. The differentiated
neuronal PC 12 cells were divided into 4 groups: Control, ETAS,
A and ETAS/A. For control, the neuronal PC 12 cells were
incubated with DMSO (0.1%, v/v) at 37°C for 48 h. For ETAS or
A, the neuronal PC 12 cells were incubated with DMSO (0.1%,
v/v) at 37°C for 24 h following incubation with ETAS (2 mg/ mL)
or A (50 M) for another 24 h, respectively. For ETAS/Athe
neuronal PC 12 cells were pre-incubated with ETAS (2 mg/ mL) for
24 h following incubation with A (50 M) for another 24 h. After
that, samples were prepared and used for each assay, as described
below.
Cell viability assay: Cell viability was measured by quantitative
colorimetric assay with MTT [33]. The MTT solution, at a final
concentration of 500 μg/mL /well, was added and cells were
incubated at 37°C for 4 h. Supernatants were then removed by
aspiration. The reaction was stopped by adding DMSO. The optical
density of each well was determined at a wavelength of 570 nm
using a microplate reader.
LDH release assay: To further determine cell viability, the levels of
extracellular LDH in the cell culture medium were measured using
an LDH assay kit according to the manufacture’s protocol. The
extracellular LDH released to the medium was represented as a
percentage of total intracellular LDH contents. The total amount of
intracellular LDH was determined by solubilizing the cells with
0.2% triton X-100.
Measurement of free radicals: The levels of intracellular ROS
were measured by the alteration in DCF fluorescent intensity. After
the medium was removed, the cells were incubated with 10 M
DCFH-DA at 37°C for 30 min. The cells were washed 3 times with
PBS to remove the extracellular DCFH-DA following re-suspension
in PBS. The optical density of each well was determined at a
wavelength of 490 nm and an emission wavelength of 540 nm using
a microplate reader.
Statistical analysis: Values are expressed as the mean ± S.D. An
analysis of variance was performed to establish that there were
significant differences between the groups, and then the
significance of the differences between the mean values was
assessed using Scheffé’s test. A P-value of < 0.05 was regarded as
significant.
Acknowledgments - This study was supported in part by a Grant-
in-Aid for Scientific Research from the Japan Ministry of
Education, Culture, Sports, Science and Technology. All authors
declare that there are no conflicts of interest between themselves
and Amino Up Chemical. Co., Ltd.
References
[1] Appleby BS, Nacopoulos D, Milano N, Zhong K, Cummings JL. (2013) A review: treatment of Alzheimer's disease discovered in repurposed
agents. Dementia and Geriatric Cognitive Disorders, 35, 1-22.
[2] Lovell MA, Xie C, Gabbita SP, Markesbery WR. (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease
brain. Free Radical Biology and Medicine, 28, 418-427.
[3] Sultana R, Newman S, Mohmmad-Abdul H, Keller JN, Butterfield DA. (2004) Protective effect of the xanthate, D609, on Alzheimer's amyloid
beta-peptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radical Research, 38, 449-458.
[4] Jiao Y, Zhang Y, Wei Y, Liu Z, An W, Guo M. (2012) Direct observation of internalization and ROS generation of amyloid -peptide in neuronal
cells at subcellular resolution. Chembiochem, 13, 2335-2338.
[5] Zhu X, Chen C, Ye D, Guan D, Ye L, Jin J, Zhao H, Chen Y, Wang Z, Wang X, Xu Y. (2012) Diammonium glycyrrhizinate upregulates PGC-1
and protects against A1-42-induced neurotoxicity. PLoS One, 7, e35823
[6] Liu R, Wu CX, Zhou D, Yang F, Tian S, Zhang L, Zhang TT, Du GH. (2012) Pinocembrin protects against -amyloid-induced toxicity in neurons
through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated
apoptosis. BMC Medicine, 10, 105.
[7] Hyeon JW, Kim SY, Park JS, Choi BY, Lee SM, Ju YR, An SS, Kim CK. (2012) The association between prion proteins and A 1-42 oligomers in
cytotoxicity and apoptosis. Biochemical and Biophysical Research Communications, 424, 214-220.
[8] Chuang DY, Chan MH, Zong Y, Sheng W, He Y, Jiang JH, Simonyi A, Gu Z, Fritsche KL, Cui J, Lee JC, Folk WR, Lubahn DB, Sun AY, Sun
GY. (2013) Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells. Journal of Neuroinflammation,
10, 15-25.
[9] Huang HL, Lin CC, Jeng KC, Yao PW, Chuang LT, Kuo SL, Hou CW. (2012) Fresh green tea and gallic acid ameliorate oxidative stress in kainic
acid-induced status epilepticus. Journal of Agricultural and Food Chemistry, 60, 2328-2336.
[10] Pavlica S, Gebhardt R. (2010) Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells. Life Sciences,
86, 79-86.
[11] Jung JY, Han CR, Jeong YJ, Kim HJ, Lim HS, Lee KH, Park HO, Oh WM, Kim SH, Kim WJ. (2007) Epigallocatechin gallate inhibits nitric oxide-
induced apoptosis in rat PC12 cells. Neuroscience Letter, 411, 222-227.
[12] Zhao L, Chen J, Su J, Lin L, Hu SQ, Li B, Zhang X, Xu Z, Chen T. (2013) In vitro antioxidant and antiproliferative activities of 5-
hydroxymethylfurfural. Journal of Agricultural and Food Chemistry, in press.
[13] Cao G, Cai H, Cai B, Tu S. (2013) Effect of 5-hydroxymethylfurfural derived from processed Cornus officinalis on the prevention of high glucose-
induced oxidative stress in human umbilical vein endothelial cells and its mechanism. Food Chemistry, 140, 273-279.
[14] Ito T, Sato A, Ono T, Goto K, Maeda T, Takanari J, Nishioka H, Komatsu K, Matsuura H. (2013) Isolation, structural elucidation, and biological
evaluation of a 5-hydroxymethyl-2-furfural derivative, asfural, from enzyme-treated asparagus extract. Journal of Agricultural and Food Chemistry,
61, 9155-9159.
[15] Wang DM, Li SQ, Zhu XY, Wang Y, Wu WL, Zhang XJ. (2013) Protective effects of hesperidin against amyloid- (A) induced neurotoxicity
through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochemical Research, 38,
1034-1044.
[16] Wei G, Chen DF, Lai XP, Liu DH, Deng RD, Zhou JH, Zhang SX, Li YW, Li H, Zhang QD. (2012) Muscone exerts neuroprotection in an
experimental model of stroke via inhibition of the fas pathway. Natural Product Communications, 7, 1069-1074.
[17] Murata N, Murakami K, Ozawa Y, Kinoshita N, Irie K, Shirasawa T, Shimizu T. (2010) Silymarin attenuated the amyloid plaque burden and
improved behavioral abnormalities in an Alzheimer's disease mouse model. Bioscience, Biotechnology, and Biochemistry, 74, 2299-2306.
[18] Chen DL, Zhang P, Lin L, Shuai O, Zhang HM, Liu SH, Wang JY. (2013) Protective effect of Bajijiasu against -amyloid-induced neurotoxicity in
PC12 cells. Cellular and Molecular Neurobiology, 33, 837-850.
564 Natural Product Communications Vol. 9 (4) 2014 Ogasawara et al.
[19] Roth A, Schaffner W, Hertel C. (1999) Phytoestrogen kaempferol (3,4',5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-
induced toxicity. Journal of Neuroscience Research, 57, 399-404.
[20] Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M. (2011)
Orally administrated cinnamon extract reduces -amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models.
PLoS One, 6, e16564.
[21] Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and
Down syndrome. Proceedings of the National Academy of Sciences of the United States of America, 82, 4245-4249.
[22] Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Miller-Hill B. (1987) The precursor of
Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736.
[23] Butterfield DA, Reed T, Newman SF, Sultana R. (2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications
in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radical Biology and Medicine, 43, 658-677.
[24] Yang HJ, Hwang JT, Kwon DY, Kim MJ, Kang S, Moon NR, Park S. (2013) Yuzu extract prevents cognitive decline and impaired glucose
homeostasis in -amyloid-infused rats. Journal of Nutrition, 143, 1093-1099.
[25] Tsai SJ, Lin CY, Mong MC, Ho MW, Yin MC. (2010) s-Ethyl cysteine and s-propyl cysteine alleviate beta-amyloid induced cytotoxicity in nerve
growth factor differentiated PC12 cells. Journal of Agricultural and Food Chemistry, 58, 7104-7108.
[26] Choi RC, Zhu JT, Leung KW, Chu GK, Xie HQ, Chen VP, Zheng KY, Lau DT, Dong TT, Chow PC, Han YF, Wang ZT, Tsim KW. (2010) A
flavonol glycoside, isolated from roots of Panax notoginseng, reduces amyloid-beta-induced neurotoxicity in cultured neurons: signaling
transduction and drug development for Alzheimer's disease. Journal of Alzheimer's Disease, 19, 795-811.
[27] Abid-Essefi S, Zaied C, Bouaziz C, Salem IB, Kaderi R, Bacha H. (2012) Protective effect of aqueous extract of Allium sativum against zearalenone
toxicity mediated by oxidative stress. Experimental and Toxicologic Pathology, 64, 689-695.
[28] Choi RC, Jiang Z, Xie HQ, Cheung AW, Lau DT, Fu Q, Dong TT, Chen J, Wang Z, Tsim KW. (2010) Anti-oxidative effects of the biennial flower
of Panax notoginseng against H2O2-induced cytotoxicity in cultured PC12 cells. Chinese Medicine, 5, 38-44.
[29] Li YX, Li Y, Qian ZJ, Kim MM, Kim SK. (2009) In vitro antioxidant activity of 5-HMF isolated from marine red alga Laurencia undulata in free-
radical-mediated oxidative systems. Journal of Microbiology and Biotechnology, 19, 1319-1327.
[30] Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. (2004) Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Annals of the
New York Academy of Sciences, 1012, 153-163.
[31] Gamba P, Leonarduzzi G, Tamagno E, Guglielmotto M, Testa G, Sottero B, Gargiulo S, Biasi F, Mauro A, Viña J, Poli G. (2011) Interaction
between 24-hydroxycholesterol, oxidative stress, and amyloid- in amplifying neuronal damage in Alzheimer's disease: three partners in crime.
Aging Cell, 10, 403-417.
[32] Lin SM, Wu JY, Su C, Ferng S, Lo CY, Chiou RY. (2012) Identification and mode of action of 5-hydroxymethyl-2-furfural (5-hmf) and 1-methyl-
1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (MTCA) as potent xanthine oxidase inhibitors in vinegars. Journal of Agricultural and Food
Chemistry, 60, 9856-9862.
[33] Denizot F, Lang R. (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved
sensitivity and reliability. Journal of Immunological Methods, 89, 271-277.
... Neuroprotection due to antioxidative effects could be another mechanism contributing to results observed in this clinical trial. In an in vitro cell study by Ogasawara et al. 2014, asparagus extract was shown to scavenge the negative effect of free radicals at the cellular level [53]. In another study, asparagus extract was demonstrated to enhance expression of cytoprotective factors such as heat shock transcription factor 1 (HSF1) and Nrf2 protein [54]. ...
... Neuroprotection due to antioxidative effects could be another mechanism contributing to results observed in this clinical trial. In an in vitro cell study by Ogasawara et al. 2014, asparagus extract was shown to scavenge the negative effect of free radicals at the cellular level [53]. In another study, asparagus extract was demonstrated to enhance expression of cytoprotective factors such as heat shock transcription factor 1 (HSF1) and Nrf2 protein [54]. ...
Article
Full-text available
Objective: The purpose of this study was to explore the clinical benefit and tolerability of IQP-AO-101 in healthy subjects with sleep complaints. Methods: This double-blind, randomized, placebo-controlled trial involved fifty subjects with sleep complaints. Subjects with a Pittsburgh Sleep Quality Index (PSQI) score between 6 and 15 were randomized to receive either IQP-AO-101 or placebo for 6 weeks, following a run-in period of one week. Sleep parameters were assessed at baseline and after 1, 4, and 6 weeks using the modified Athens Insomnia Scale (mAIS). Subjects were also instructed to wear an activity tracker and keep a sleep diary during the study. Other questionnaires administered were the Frankfurt Attention Inventory (FAIR-2) and the Profile of Mood States (POMS-65). Blood samples for safety laboratory parameters were taken before and at the end of the study. Results: After 6 weeks, subjects who consumed IQP-AO-101 reported significant improvements in mAIS scores compared with placebo, including mAIS total score (11.76 ± 6.85 vs 4.00 ± 4.80; p < 0.001); night parameters composite score (5.20 ± 3.80 vs 2.04 ± 3.16; p = 0.001); and day parameters composite score (6.56 ± 4.10 vs 1.96 ± 2.65; p < 0.001). All individual parameters (Items 1 to 8) were also significantly improved from baseline after 6 weeks of IQP-AO-101 intake. Analysis of variance with baseline values as covariates showed statistically significant improvements across all individual parameters for IQP-AO-101 when compared to placebo. The measurements using the activity tracker, sleep diary, FAIR-2, and POMS did not reveal any significant differences between groups. No adverse effects related to the intake of IQP-AO-101 were reported. Tolerability was rated as very good by all the subjects and by the investigator for all cases. Conclusions: In this study, IQP-AO-101 was well tolerated and efficacious for promoting sleep and enhancing daytime performance in subjects with moderate sleep disturbances. Clinical trial registration: This trial is registered with ClinicalTrials.gov, no. NCT03114696.
... For example, the favonol glycosides and terpenoids contained in the Ginkgo biloba extract may be efective in improving memory and brain dysfunction by scavenging active oxygen and improving blood circulation [20][21][22], though this topic remains highly understudied. ETAS ® 50, used in this present pilot trial, has previously shown some efects in the brain of diferent organisms [23]. ...
Article
Full-text available
Dementia is a disease of substantial national concern in a superaging society in Japan. Thus, the treatments targeting this disease are of high priority. However, pharmaceutical treatments are under development and invasive. Hence, many alternative treatments, which are less invasive, are tried, and some of them are supposed to work for dementia symptoms. ETAS®50 is one of these treatments. ETAS®50, a standardized extract of the Asparagus officinalis stem with heat shock protein-inducing activity, is a functional food. ETAS®50 has antistress, autonomic nerve regulation, and sleep quality improvement effects in humans and could contribute to relieving dementia symptoms. This double-blind crossover pilot trial aimed to examine the effects of ETAS®50. A total of 27 patients with mild-to-moderate dementia between October 2018 and February 2020 were included in the trial. ETAS®50 was consumed for 12 weeks and then a placebo for 12 weeks. A significant difference in the mean score of the severity of symptoms in the Neuropsychiatric Inventory Questionnaire (NPI-Q-a) was observed between the ETAS®50 period (0.56 ± 1.72 points) and placebo period (−0.67 ± 2.34 points) (p=0.045). Between-group comparisons with respect to the items of NPI-Q-a also showed a significant decrease in symptoms in the ETAS®50 period compared with the placebo period (p=0.015 for agitation and p=0.045 for depression). In addition, we observed that scores for apathy tended to improve in the ETAS®50 period (p=0.058).
... On the other hand, the in vitro and in vivo neuroprotective effects of EAS have been well demonstrated. Preincubation of differentiated neuronal PC-12 cells with EAS significantly restored amyloid β (Aβ)-induced reduction in cell viability, which was accompanied by reduced levels of intracellular reactive oxygen species [46]. Based on the findings obtained from this in vitro study using the cultured cell line, it was clarified that EAS intake improved the impairment of conditioned fear memory in senescence-accelerated mouse prone 8 (SAMP8) mice [47]. ...
Article
Full-text available
Excessive host inflammation following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with severity and mortality in coronavirus disease 2019 (COVID-19). We recently reported that the SARS-CoV-2 spike protein S1 subunit (S1) induces pro-inflammatory responses by activating toll-like receptor 4 (TLR4) signaling in macrophages. A standardized extract of Asparagus officinalis stem (EAS) is a unique functional food that elicits anti-photoaging effects by suppressing pro-inflammatory signaling in hydrogen peroxide and ultraviolet B-exposed skin fibroblasts. To elucidate its potential in preventing excessive inflammation in COVID-19, we examined the effects of EAS on pro-inflammatory responses in S1-stimulated macrophages. Murine peritoneal exudate macrophages were co-treated with EAS and S1. Concentrations and mRNA levels of pro-inflammatory cytokines were assessed using enzyme-linked immunosorbent assay and reverse transcription and real-time polymerase chain reaction, respectively. Expression and phosphorylation levels of signaling proteins were analyzed using western blotting and fluorescence immunomicroscopy. EAS significantly attenuated S1-induced secretion of interleukin (IL)-6 in a concentration-dependent manner without reducing cell viability. EAS also markedly suppressed the S1-induced transcription of IL-6 and IL-1β. However, among the TLR4 signaling proteins, EAS did not affect the degradation of inhibitor κBα, nuclear translocation of nuclear factor-κB p65 subunit, and phosphorylation of c-Jun N-terminal kinase p54 subunit after S1 exposure. In contrast, EAS significantly suppressed S1-induced phosphorylation of p44/42 mitogen-activated protein kinase (MAPK) and Akt. Attenuation of S1-induced transcription of IL-6 and IL-1β by the MAPK kinase inhibitor U0126 was greater than that by the Akt inhibitor perifosine, and the effects were potentiated by simultaneous treatment with both inhibitors. These results suggest that EAS attenuates S1-induced IL-6 and IL-1β production by suppressing p44/42 MAPK and Akt signaling in macrophages. Therefore, EAS may be beneficial in regulating excessive inflammation in patients with COVID-19.
... In addition, the overexpression of HSP70 reduces ROS induced by hypoxia and glucose deprivation 18 www.nature.com/scientificreports/ a unique inducible HSP70 could protect cells against ROS under various stress conditions. Moreover, EAS was found to significantly reduce the amyloid beta peptide-induced production of ROS in differentiated rat PC12 cells 40 . In this study, EAS treatment significantly inhibited ROS expression in both normal and HS conditions in bovine CG cells by activating GSH generation and antioxidant enzymes, such as SOD and PRDX. ...
Article
Full-text available
Heat shock (HS) protein 70 (HSP70), a well-known HS-induced protein, acts as an intracellular chaperone to protect cells against stress conditions. Although HS induces HSP70 expression to confer stress resistance to cells, HS causes cell toxicity by increasing reactive oxygen species (ROS) levels. Recently, a standardized extract of Asparagus officinalis stem (EAS), produced from the byproduct of asparagus, has been shown to induce HSP70 expression without HS and regulate cellular redox balance in pheochromocytoma cells. However, the effects of EAS on reproductive cell function remain unknown. Here, we investigated the effect of EAS on HSP70 induction and oxidative redox balance in cultured bovine cumulus-granulosa (CG) cells. EAS significantly increased HSP70 expression; however, no effect was observed on HSP27 and HSP90 under non-HS conditions. EAS decreased ROS generation and DNA damage and increased glutathione (GSH) synthesis under both non-HS and HS conditions. Moreover, EAS synergistically increased HSP70 and HSF1 expression and increased progesterone levels in CG cells. Treatment with an HSP70 inhibitor significantly decreased GSH level, increased ROS level, and decreased HSF1 , Nrf2 , and Keap1 expression in the presence of EAS. Furthermore, EAS significantly increased progesterone synthesis. Thus, EAS improves HSP70-mediated redox balance and cell function in bovine CG cells.
... These results indicate that EAS with unique inducible HSP70 could protect cells against ROS under various stress conditions. Moreover, EAS was found to signi cantly reduce the amyloid beta peptide-induced production of ROS in differentiated PC12 cells 39 . In the present study, EAS treatment signi cantly inhibited ROS expression in both normal and HS conditions in bovine cumulus-granulosa cells by activating GSH generation and antioxidant enzymes, such as SOD and PRDX. ...
Preprint
Full-text available
Heat shock protein 70 (HSP70) is a well-known heat shock (HS)-induced protein that acts as an intracellular chaperone to protect cells against stress conditions. Although HS induces HSP70 expression to acquire stress-resistant ability to cells, HS causes toxicity to cells by increasing reactive oxygen species (ROS). Recently, a standardized extract of Asparagus officinalis stem (EAS), produced from the by-product of asparagus, was found to induce HSP70 expression without HS and regulate cellular redox balance in the cells. However, the effect of EAS on the function of reproductive cells remains unknown. In the present study, we investigated the effect of EAS on HSP70 induction and oxidative redox balance in cultured bovine cumulus-granulosa(CG) cells. EAS significantly increased HSP70 expression, whereas no effect was observed in HSP27 and − 90 under non-heat stress condition. EAS decreased ROS generation and DNA damage, and increased glutathione (GSH) synthesis both under non-HS and HS conditions. Moreover, EAS synergistically increased HSP70 and HSF1 expression. EAS also increased progesterone (P4) levels in CG cells. HSP70 inhibitor significantly decreased GSH and increased ROS, as well as decreased HSF1 , Nrf2 , and Keap1 in the presence of EAS. These results suggest that EAS regulates redox balance through HSP70 in bovine CG cells.
... 3 A standardized extract of Asparagus officinalis stem (EAS) is prepared from the lower residual parts of Asparagus. 4 Previous studies have reported several biological activities of EAS, such as neuroprotective effects, 5,6 modulation of sleep stages, 7 beneficial effects against psychological stress, 8 and anti-oxidative activity. 9 Human skin is composed of various types of cells, including keratinocytes, melanocytes, and fibroblasts. ...
Article
Full-text available
A standardized extract of Asparagus officinalis stem (EAS) is prepared from the lower residual parts of the plant. It is known to have antioxidative and neuroprotective activities. The purpose of the present study was to investigate the effects of EAS on photoaging in the epidermal layer of the skin using cultured keratinocytes. Normal human epidermal keratinocytes were irradiated or unirradiated with UV-B (10 mJ/cm²) and incubated with EAS (0.5 or 2 mg/mL) or vehicle. After 3 or 13 hours, molecular examinations were performed, and after 24 or 48 hours, cell viabilities were determined by a CCK-8 assay. EAS treatment upregulated the mRNA level of heparin-binding EGF-like growth factor in cultured keratinocytes 13 hours after UV-B irradiation. On the other hand, EAS downregulated caspase-9 and endothelin-1 mRNA levels in UV-treated keratinocytes. EAS also increased cell viability on keratinocytes 24 hours after UV-B irradiation. These results suggested that EAS might accelerate the migration of keratinocytes and protect the cells against damage induced by UV-B irradiation. Furthermore, EAS might inhibit melanocyte proliferation and UV-induced hyperpigmentation.
... It is a unique eco-friendly functional food that attenuates sleep deprivation-induced stress responses, promotes good sleep, and increases salivary secretory immunoglobulin A levels in mice and humans [13][14][15]. In addition to its antistress effects, later studies demonstrated the beneficial effects of ETAS 50 on brain functions, including the ability to ameliorate cognitive impairment in senescenceaccelerated mice [16], protect neuronal PC-12 cells from amyloid -induced cytotoxicity [17], and improve learning ability in young healthy rats [18]. ...
Article
Full-text available
We recently reported that ETAS 50, a standardized extract from the Asparagus officinalis stem, exerted anti-inflammatory effects on ultraviolet-B- (UV-B-) irradiated normal human dermal fibroblasts (NHDFs) by inhibiting nuclear factor- κ B p65 nuclear import and the resulting interleukin-1 β (IL-1 β ) expression. To further elucidate the antiphotoaging potency of ETAS 50, we examined the anti-inflammatory effects on UV-B-irradiated NHDFs by focusing on the stress-activated mitogen-activated protein kinase (MAPK) and Akt signaling pathways. NHDFs were treated with 1 mg/mL of ETAS 50 or dextrin (vehicle control) after UV-B irradiation (20 mJ/cm ² ) for different time periods. Phosphorylation levels of c-Jun N-terminal kinase (JNK), p38 MAPK, and Akt were analyzed by western blotting. IL-6 mRNA levels were analyzed by real-time polymerase chain reaction. UV-B-irradiated NHDFs showed increased phosphorylation levels of JNK, p38 MAPK, and Akt, as well as increased mRNA levels of IL-6. ETAS 50 treatment after UV-B irradiation suppressed the increased phosphorylation levels of Akt without affecting those of JNK and p38 MAPK. ETAS 50 as well as Akt inhibitor Perifosine repressed UV-B irradiation-induced IL-6 mRNA expression. These results suggest that ETAS 50 treatment represses UV-B irradiation-induced IL-6 expression by suppressing Akt phosphorylation. The present findings demonstrate the potential of ETAS 50 to prevent photoaging by attenuating UV-B irradiation-induced proinflammatory responses in skin fibroblasts.
... A recent study also showed that ETAS 50 supplementation reduced the feelings of dysphoria and fatigue, ameliorated the quality of sleep, and enhanced stressload performance as well as increasing salivary secretory immunoglobulin A levels in healthy adults [16]. In addition to these anti-stress effects, ETAS 50 has antiaging potencies via its ability to ameliorate cognitive impairment in senescenceaccelerated mice [17], to protect neuronal PC-12 cells from amyloid peptide-induced oxidative stress and cytotoxicity [18], and to improve learning ability in young healthy rats [19]. ...
Article
Full-text available
Ultraviolet (UV) irradiation induces proinflammatory responses in skin cells, including dermal fibroblasts, accelerating premature skin aging (photoaging). ETAS 50, a standardized extract from the Asparagus officinalis stem, is a novel and unique functional food that suppresses proinflammatory responses of hydrogen peroxide-stimulated skin fibroblasts and interleukin- (IL-) 1 β -stimulated hepatocytes. To elucidate its antiphotoaging potencies, we examined whether ETAS 50 treatment after UV-B irradiation attenuates proinflammatory responses of normal human dermal fibroblasts (NHDFs). UV-B-irradiated NHDFs showed reduced levels of the cytosolic inhibitor of nuclear factor- κ B α (I κ B α ) protein and increased levels of nuclear p65 protein. The nuclear factor- κ B nuclear translocation inhibitor JSH-23 abolished UV-B irradiation-induced IL-1 β mRNA expression, indicating that p65 regulates transcriptional induction. ETAS 50 also markedly suppressed UV-B irradiation-induced increases in IL-1 β mRNA levels. Immunofluorescence analysis revealed that ETAS 50 retained p65 in the cytosol after UV-B irradiation. Western blotting also showed that ETAS 50 suppressed the UV-B irradiation-induced increases in nuclear p65 protein. Moreover, ETAS 50 clearly suppressed UV-B irradiation-induced distribution of importin- α protein levels in the nucleus without recovering cytosolic I κ B α protein levels. These results suggest that ETAS 50 exerts anti-inflammatory effects on UV-B-irradiated NHDFs by suppressing the nuclear import machinery of p65. Therefore, ETAS 50 may prevent photoaging by suppressing UV irradiation-induced proinflammatory responses of dermal fibroblasts.
... Enzyme-treated asparagus extract (ETAS) is prepared from the lower, residual parts of asparagus (4). Some studies have reported the functionalities of ETAS, such as its neuroprotective effects (5,6), modulation of sleep stages (7), beneficial effects against psychological stress (8) and anti-oxidative activity (9). ...
Article
Enzyme-treated asparagus extract (ETAS) is prepared from the lower, residual parts of asparagus, and some functionalities, such as anti-oxidative and neuroprotective activities, have been suggested. The purpose of the present study was to investigate the effects of ETAS on photoaging in the epidermal layer of the skin using cultured keratinocytes. Normal human epidermal keratinocytes were irradiated or left unirradiated with UV-B (10 mJ/cm2) and incubated with ETAS (0.5 or 2 mg/mL) or vehicle. After 3 or 13 h, molecular examinations were performed, and after 24 or 48 h, cell viabilities were determined by a CCK-8 assay. ETAS addition may induce keratinocyte migration and proliferation as well as apoptosis under molecular examination. These results suggest that ETAS might accelerate turnover of keratinocytes.
... In in vitro study, the Aβ-peptide induced cell death in PC12 cells was significantly inhibited by pre-treatment with ETAS, and also suppressed intracellular ROS production [6]. We have shown that rutin, which is one of the primary flavonoids in buckwheat, in the diet may provide a protective effect against spatial memory impairment accompanied by hippocampal pyramidal neuron loss in rats [15]. ...
Article
Full-text available
Enzyme-treated asparagus extract (ETAS) contains various phytochemicals. It has been reported that ETAS protected early cognitive impairment of SAMP8 mice and Aβ-induced reduction of PC12 cell viability. In addition, ETAS had several functions on healthy people. The purpose of the present study was to investigate the effects of ETAS on normal memory function of rats and neurite-outgrowth of PC12 cells. ETAS significantly accelerated learning acquisition in in vivo and neurite-outgrowth in in vitro study. In conclusion, ETAS affected on memory function in early stage in normal rats. The basis of this effect may induce neurite-outgrowth in neurons.
Article
Full-text available
Background The bark of magnolia has been used in Oriental medicine to treat a variety of remedies, including some neurological disorders. Magnolol (Mag) and honokiol (Hon) are isomers of polyphenolic compounds from the bark of Magnolia officinalis, and have been identified as major active components exhibiting anti-oxidative, anti-inflammatory, and neuroprotective effects. In this study, we investigate the ability of these isomers to suppress oxidative stress in neurons stimulated by the ionotropic glutamate receptor agonist N-methyl-D-aspartate (NMDA) and oxidative and inflammatory responses in microglial cells activated by interferon-γ (IFNγ) and lipopolysaccharide (LPS). We also attempt to elucidate the mechanism and signaling pathways involved in cytokine-induced production of reactive oxygen species (ROS) in microglial cells. Methods Dihydroethidium (DHE) was used to assay superoxide production in neurons, while CM-H2DCF-DA was used to test for ROS production in murine (BV-2) and rat (HAPI) immortalized microglial cells. NADPH oxidase inhibitors (for example, diphenyleneiodonium (DPI), AEBSF, and apocynin) and immunocytochemistry targeting p47phox and gp91phox were used to assess the involvement of NADPH oxidase. Western blotting was used to assess iNOS and ERK1/2 expression, and the Griess reaction protocol was employed to determine nitric oxide (NO) concentration. Results Exposure of Hon and Mag (1–10 μM) to neurons for 24 h did not alter neuronal viability, but both compounds (10 μM) inhibited NMDA-stimulated superoxide production, a pathway known to involve NADPH oxidase. In microglial cells, Hon and Mag inhibited IFNγ±LPS-induced iNOS expression, NO, and ROS production. Studies with inhibitors and immunocytochemical assay further demonstrated the important role of IFNγ activating the NADPH oxidase through the p-ERK-dependent pathway. Hon and, to a lesser extent, Mag inhibited IFNγ-induced p-ERK1/2 and its downstream pathway for ROS and NO production. Conclusion This study highlights the important role of NADPH oxidase in mediating oxidative stress in neurons and microglial cells and has unveiled the role of IFNγ in stimulating the MAPK/ERK1/2 signaling pathway for activation of NADPH oxidase in microglial cells. Hon and Mag offer anti-oxidative or anti-inflammatory effects, at least in part, through suppressing IFNγ-induced p-ERK1/2 and its downstream pathway.
Article
Full-text available
Background/aims: Many compounds that have already been approved for alternate diagnoses have been studied in relation to Alzheimer's disease (AD). The purpose of this review is to summarize these studies and discuss the rationale and benefits of repurposing drugs for AD treatment. Methods: Studies of drugs related to AD treatment that were relevant to a disease-modifying mechanism of action (MOA) and are already approved by the Food and Drug Administration for non-AD diagnoses were collected from PubMed. Results: Many drugs already approved for the treatment of other diseases have been studied in relation to AD treatment. Numerous drugs with known toxicity profiles have the potential to be repurposed as a treatment for AD. Conclusion: Known MOA, toxicology, and pharmacodynamic profiles would accelerate the process and increase the odds of finding a more timely disease-modifying treatment for AD.
Article
Marine red algae of genus Laurencia are becoming the most important resources to produce unique natural metabolites with wide bioactivities. However, reports related to Laurencia undulata, an edible species used as folk herb, are rarely found to date. In this research, 5-hydroxymethyl-2-furfural (5-HMF) was isolated and characterized by nuclear magnetic resonance (NMR) from Laurencia undulata as well as other marine algae. The following characteristics of 5-HMF were systematically evaluated: its antioxidant activities, such as typical free-radicals scavenging in vitro by electron spin resonance spectrometry (ESR) and intracellular reactive oxygen species (ROS) scavenging; membrane protein oxidation; oxidative enzyme myeloperoxidase (MPO) inhibition; as well as expressions of antioxidative enzymes glutathione (GSH) and superoxide dismutase (SOD) on the gene level using the polymerase chain reaction (PCR) method. The results demonstrated that 5-HMF could be developed as a novel marine natural antioxidant or potential precursor for practical applications in the food, cosmetic, and pharmaceutical fields.
Article
5-HMF is widely presented in foods, and produced through the degradation of hexoses and Maillard reaction during heat treatment of foods containing reducing sugars and amino acids in acid environment. However, controversial conclusions on the biological effects of 5-HMF have been drew in previous studies. Therefore, the main aim of this study was to investigate the antioxidant and antiproliferative activities of 5-HMF. The 2, 2'-azinobis-3- ethylbenzothiazolin-6-sulfonic acid (ABTS) assay, 1, 1-diphenyl-2-picryhydrazyl (DPPH) assay, and hemolysis assay induced by 2, 2'-azobis-(2-amidinopropane) dihydrochloride (AAPH) were performed to evaluate the antioxidant capacity of 5-HMF. The results showed that 5-HMF exhibited novel antioxidant activity by scavenging the ABTS and DPPH free radicals, and inhibited the AAPH-induced hemolysis in a dose-dependent manner. In the hemolysis assay, the reduction of ROS and MDA contents, and the increase in enzyme activities of SOD, CAT and GPx were found in erythrocytes pretreated with 5-HMF, which demonstrated that 5-HMF could prevent the peroxidation from source to protect the erythrocytes. It was also verified by observation the morphological changes of erythrocytes using an atomic force microscopy (AFM). The inhibitory effect of 5-HMF on human cancer cells proliferation was investigated by MTT assay, flow cytometric analysis and TUNEL and DAPI co-staining assay. The results showed that 5-HMF showed higher antiproliferative activity on human melanoma A375 cells than other cell lines. Further investigation on the action mechanisms revealed that 5-HMF could induce A375 cell apoptosis and G0/G1 cell cycle arrest. Meanwhile, the A375 cells apoptosis 5-HMF-induced was characterized by TUNEL and DAPI co-staining assay. These findings suggest that 5-HMF could be developed as a novel natural antioxidant with potential applications in cancer chemoprevention.
Article
Misfolding of prion protein (PrP to PrPSc) can cause neurodegenerative prion diseases. As a glycosylphosphatidylinositol (GPI)-anchored membrane protein, the normal form of PrP (PrPC) can function as a receptor for ligands in the extracellular space. PrPC was suggested to be involved in memory, synaptic neuronal communication, and anti-oxidation as a neuroprotective agent. The recently identified interaction between PrPC and Aβ1–42 oligomers suggested another role for PrP as a receptor for Aβ1–42 oligomers, thereby influencing cytotoxicity and apoptosis.Here, the association between PrPC and Aβ1–42 oligomers was investigated by visualizing protein localization in neuronal cells by immunocytochemistry. Aβ1–42 oligomer-induced cytotoxicity was tested in respective expressions of PrPC by using mouse neuroblastoma-2a (N2a) cells, the prion protein overexpressed cells (L2-2B1), and a Prnp-null mouse hippocampal cell line (HpL 3–4). Moreover, apoptotic proteins such as caspase-8 were used to assess the effect of PrPC on Aβ1–42 oligomer-mediated apoptosis. In L2-2B1 and HpL 3–4 cells, the difference in the cytotoxicity of Aβ1–42 oligomers could be clearly distinguished. In addition, Aβ1–42 oligomers induced mitochondria dysfunction, reactive oxygen species (ROS) generation, and calcium influx PrPC-dependently. Apoptosis, related to mitochondria dysfunction, was further investigated to determine the cytotoxic pathway; the results suggest that PrPC could be involved in both the intrinsic and extrinsic apoptotic pathways. Finally, cells with abundant PrPC expression seemed to be more susceptible to Aβ1–42 oligomer toxicity, suggesting the importance of the level of PrPC expression in the induction of apoptosis.
Article
A novel 5-hydroxymethyl-2-furfural (HMF; 1) derivative, which is named as asfural (compound 2), was isolated from enzyme-treated asparagus extract (ETAS) along with HMF (1) as a heat shock protein 70 (HSP70) inducible compound. The structure of compound 2 was elucidated on the basis of its spectroscopic data from HREIMS and NMR, while the absolute configuration was determined using chiral HPLC analysis, compared to two synthesized compounds, (S)- and (R)-asfural. As a result, compound 2 derived from ETAS was assigned as (S)-(2-formylfuran-5-yl)methyl 5-oxopyrrolidine-2-carboxylate. When compound 2, synthesized (S)- and (R)-asfural, and HMF (1) were evaluated in terms of HSP70 mRNA expression-enhancing activity in HL-60 cells, compound 2 and (S)-asfural significantly increased the expression level in a concentration dependent manner. HMF (1) also showed significant activity at 0.25 mg/mL.
Article
Beta-amyloid peptide (Aβ), a major protein component of senile plaques associated with Alzheimer’s disease (AD), is also directly neurotoxic. Mitigation of Aβ-induced neurotoxicity is thus a possible therapeutic approach to delay or prevent onset and progression of AD. This study evaluated the protective effect of Bajijiasu (β- d-fructofuranosyl (2–2) β- d-fructofuranosyl), a dimeric fructose isolated from the Chinese herb Radix Morinda officinalis, on Aβ-induced neurotoxicity in pheochromocytoma (PC12) cells. Bajijiasu alone had no endogenous neurotoxicity up to 200 μM. Brief pretreatment with 10–40 μM Bajijiasu (2 h) significantly reversed the reduction in cell viability induced by subsequent 24 h exposure to Aβ25–35 (21 μM) as measured by MTT and LDH assays, and reduced Aβ25–35-induced apoptosis as indicated by reduced annexin V-EGFP staining. Bajijiasu also decreased the accumulation of intracellular reactive oxygen species and the lipid peroxidation product malondialdehyde in PC12 cells, upregulated expression of glutathione reductase and superoxide dismutase, prevented depolarization of the mitochondrial membrane potential (Ψm), and blocked Aβ25–35-induced increases in [Ca2+]i . Furthermore, Bajijiasu reversed Aβ25–35-induced changes in the expression levels of p21, CDK4, E2F1, Bax, NF-κB p65, and caspase-3. Bajijiasu is neuroprotective against Aβ25–35-induced neurotoxicity in PC12 cells, likely by protecting against oxidative stress and ensuing apoptosis.
Article
Our preliminary study revealed that dementia induced by β-amyloid accumulation impairs peripheral glucose homeostasis (unpublished). We therefore evaluated whether long-term oral consumption of yuzu (Citrus junos Tanaka) extract improves cognitive dysfunction and glucose homeostasis in β-amyloid-induced rats.Male rats received hippocampal CA1 infusions of β-amyloid (25-35) [plaque forming β-amyloid; Alzheimer disease (AD)] or β-amyloid (35-25) [non-plaque forming β-amyloid; C (non-Alzheimer disease control)] at a rate of 3.6 nmol/d for 14 d. AD rats were divided into 2 dietary groups that received either 3% lyophilized 70% ethanol extracts of yuzu (AD-Y) or 3% dextrin (AD-C) in high-fat diets (43% energy as fat). The AD-C group exhibited greater hippocampal β-amyloid deposition, which was not detected in the C group, and attenuated hippocampal insulin signaling. Yuzu treatment prevented β-amyloid accumulation, increased tau phosphorylation, and attenuated hippocampal insulin signaling observed in AD-C rats. Consistent with β-amyloid accumulation, the AD-C rats experienced cognitive dysfunction, which was prevented by yuzu. AD-C rats gained less weight than did C rats due to decreased feed consumption, and yuzu treatment prevented the decrease in feed consumption. Serum glucose concentrations were higher in AD-C than in C rats at 40-120 min after glucose loading during an oral-glucose-tolerance test, but not at 0-40 min. Serum insulin concentrations were highly elevated in AD-C rats but not enough to lower serum glucose to normal concentrations, indicating that rats in the AD-C group had insulin resistance and a borderline diabetic state. Although AD-C rats were profoundly insulin resistant, AD-Y rats exhibited normal first and second phases of glucose tolerance and insulin sensitivity and secretion. In conclusion, yuzu treatment prevented the cognitive dysfunction and impaired energy and glucose homeostasis induced by β-amyloid infusion.
Article
The aim of this study was to investigate the protective effect of 5-HMF on human umbilical vein endothelial cells (HUVECs) injured by high glucose in vitro, and the mechanism underlying this process. Our results demonstrated that high glucose-induced oxidative stress in HUVECs was mainly mediated through activation of reactive oxygen species (ROS), Jun N-kinase 2/3 (JNK2/3) and plasma interleukin-8 (IL-8), and inactivation of phosphorylated protein kinase B (P-Akt). Treatment of HUVECs with media containing high glucose (4.5%) in the presence of 5-HMF (100, 200 and 400μM) resulted in significant inhibition of high glucose-induced oxidative stress and expression of JNK1 and JNK2/3. Furthermore, 5-HMF rapidly inhibited high glucose-induced activation of IL-8, a downstream activator of P-Akt. Diabetes mellitus can cause a wide variety of vascular complications and high glucose can induce vascular endothelial cell apoptosis. Free radicals are formed disproportionately in diabetes by glucose oxidation. The finding of this study highlights the pharmacological application of 5-HMF for preventing cardiovascular and diabetes mellitus diseases, and provides the theoretical basis for further development of a Cornus officinalis agent for diabetes-associated vascular diseases.
Article
Amyloid-β (Aβ) is known to exert cytotoxic effects by inducing mitochondrial dysfunction. Additionally, the mitochondrial voltage-dependent anion channel 1 (VDAC1), which is involved in the release of apoptotic proteins with possible relevance in Alzheimer's disease (AD) neuropathology, plays an important role in maintaining mitochondrial function and integrity. However, the application of therapeutic drugs, especially natural products in (AD) therapy via VDAC1-regulated mitochondrial apoptotic pathway has not aroused extensive attention. In the present study, we investigated neuroprotective effects of hesperidin, a bioactive flavonoid compound, on Aβ25-35-induced neurotoxicity in PC12 cells and also examined the potential cellular signalling mechanism. Our results showed that treatment with hesperidin significantly inhibited Aβ25-35-induced apoptosis by reversing Aβ-induced mitochondrial dysfunction, including the mitochondrial permeability transition pore opening, intracellular free calcium increase and reactive oxygen species production. Further study indicated that hesperidin can increase the level of VDAC1 phosphorylation through enhancing the activity of the glycogen synthasekinase-3β and decrease the level of hexokinaseI in mitochondrial, resulting in mitochondrial release of cytochrome c. Furthermore, hesperidin inhibited mitochondria-dependent downstream caspase-mediated apoptotic pathway, such as that involving caspase-9 and caspase-3. These results demonstrate that hesperidin can protect Aβ-induced neurotoxicity via VDAC1-regulated mitochondrial apoptotic pathway, and they raise the possibility that hesperidin could be developed into a clinically valuable treatment for AD and other neuronal degenerative diseases associated with mitochondrial dysfunction.